TGTX
Price
$15.72
Change
-$0.31 (-1.93%)
Updated
Dec 8, 6:59 PM EST
79 days until earnings call
VSTM
Price
$7.36
Change
-$0.23 (-3.03%)
Updated
Dec 8, 6:59 PM EST
Ad is loading...

Compare trend and price TGTX vs VSTM

Header iconTGTX vs VSTM Comparison
Open Charts TGTX vs VSTMBanner chart's image
TG Therapeutics
Price$15.72
Change-$0.31 (-1.93%)
Volume$2.57M
CapitalizationN/A
Verastem
Price$7.36
Change-$0.23 (-3.03%)
Volume$29.98K
CapitalizationN/A
View a ticker or compare two or three
TGTX vs VSTM Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
TGTX vs. VSTM commentary
Dec 10, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGTX is a Hold and VSTM is a StrongBuy.

COMPARISON
Comparison
Dec 10, 2023
Stock price -- (TGTX: $15.72 vs. VSTM: $7.36)
Brand notoriety: TGTX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TGTX: 72% vs. VSTM: 97%
Market capitalization -- TGTX: $1.92B vs. VSTM: $165.5M
TGTX [@Biotechnology] is valued at $1.92B. VSTM’s [@Biotechnology] market capitalization is $165.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGTX’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • TGTX’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than TGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGTX’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 6 bullish TA indicator(s).

  • TGTX’s TA Score: 4 bullish, 4 bearish.
  • VSTM’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than TGTX.

Price Growth

TGTX (@Biotechnology) experienced а +13.67% price change this week, while VSTM (@Biotechnology) price change was +4.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10161.68%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +27.10%.

Reported Earning Dates

TGTX is expected to report earnings on Feb 27, 2024.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+10161.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for TGTX with price predictions.
OPEN
A.I.dvisor published
a Summary for VSTM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TGTX($1.92B) has a higher market cap than VSTM($166M). VSTM YTD gains are higher at: 52.381 vs. TGTX (32.883). TGTX has higher annual earnings (EBITDA): -12.4M vs. VSTM (-73.06M). VSTM has more cash in the bank: 166M vs. TGTX (151M). TGTX has less debt than VSTM: TGTX (11M) vs VSTM (42M). TGTX has higher revenues than VSTM: TGTX (190M) vs VSTM (0).
TGTXVSTMTGTX / VSTM
Capitalization1.92B166M1,157%
EBITDA-12.4M-73.06M17%
Gain YTD32.88352.38163%
P/E RatioN/AN/A-
Revenue190M0-
Total Cash151M166M91%
Total Debt11M42M26%
FUNDAMENTALS RATINGS
TGTX vs VSTM: Fundamental Ratings
TGTX
VSTM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
3659
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VSTM's Valuation (42) in the Biotechnology industry is in the same range as TGTX (73). This means that VSTM’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (72) in the Biotechnology industry is in the same range as VSTM (100). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's SMR Rating (94) in the Biotechnology industry is in the same range as VSTM (98). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as VSTM (59). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VSTM (100). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGTXVSTM
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 7 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHSGX22.940.13
+0.57%
JHancock U.S. Growth R4
BMPIX100.970.49
+0.49%
ProFunds Materials UltraSector Inv
TRWRX20.100.06
+0.30%
Transamerica International Equity R
GSLIX15.560.03
+0.19%
Goldman Sachs Large Cap Value Instl
HRLYX8.78-0.01
-0.11%
Hartford Real Asset Y